IGC Pharma (IGC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for August 23, 2024, with voting open until August 22, 2024 at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by August 11, 2024.
Meeting location is 10224 Falls Road, Potomac, MD, with in-person voting available upon request of a legal proxy.
Voting matters and shareholder proposals
Election of two directors: Richard Prins and Terry Lierman, both recommended by the board.
Ratification of Manohar Chowdhry & Associates as independent registered public accounting firm for fiscal year 2025.
Approval of grant of 5,000,000 shares under the 2018 Omnibus Incentive Plan for employees, advisors, directors, and consultants, based on performance and vesting metrics set by the board or CEO.
Proposal to allow adjournment or postponement of the meeting if necessary for further proxy solicitation.
Board of directors and corporate governance
Board recommends all proposals, including director nominees and incentive plan share grants.
Latest events from IGC Pharma
- CALMA trial nears completion and MINT-AD AI platform set for beta launch amid favorable regulations.IGC
Status update18 Feb 2026 - IGC-AD1 demonstrates strong clinical promise for Alzheimer's agitation, driving major growth potential.IGC
Investor presentation18 Feb 2026 - AI-driven Alzheimer's drug developer registers 978,235 shares for resale by stockholders.IGC
Registration Filing16 Dec 2025 - Secondary offering of nearly 1M shares; no proceeds to company; lead drug in Phase 2 trials.IGC
Registration Filing16 Dec 2025 - Resale of 4.7M shares by investors; no proceeds to company; lead Alzheimer's drug in Phase 2.IGC
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, auditor ratification, equity grants, and a major share increase.IGC
Proxy Filing2 Dec 2025 - Proxy seeks approval for director elections, auditor, equity grant, and quadrupling authorized shares.IGC
Proxy Filing2 Dec 2025 - Annual meeting to vote on director elections, auditor ratification, and a 5M-share equity grant.IGC
Proxy Filing2 Dec 2025 - Board recommends electing directors, approving auditor, incentive plan, and share increase.IGC
Proxy Filing2 Dec 2025